1.
Kiyani M, Clanahan O, Silverman MA. Heterogeneity in Infection Reporting Across Covalent Bruton Tyrosine Kinase Inhibitor Studies in B-Cell Malignancies: A Systematic Review. J Hematol. 2026;15(5):219-224. doi:10.14740/jh2233